日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer

一项随机II期研究,比较卡铂和紫杉醇联合利尼凡尼或安慰剂治疗晚期非鳞状非小细胞肺癌的疗效

Ramalingam, Suresh S; Shtivelband, Mikhail; Soo, Ross A; Barrios, Carlos H; Makhson, Anatoly; Segalla, José G M; Pittman, Kenneth B; Kolman, Petr; Pereira, Jose R; Srkalovic, Gordan; Belani, Chandra P; Axelrod, Rita; Owonikoko, Taofeek K; Qin, Qin; Qian, Jiang; McKeegan, Evelyn M; Devanarayan, Viswanath; McKee, Mark D; Ricker, Justin L; Carlson, Dawn M; Gorbunova, Vera A

Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer

贝伐珠单抗联合曲妥珠单抗和卡培他滨作为HER-2阳性局部复发或转移性乳腺癌一线治疗的II期研究

Martín, Miguel; Makhson, Anatoly; Gligorov, Joseph; Lichinitser, Mikhail; Lluch, Ana; Semiglazov, Vladimir; Scotto, Nana; Mitchell, Lada; Tjulandin, Sergei

Extralesional resection for tumours of the pelvic bones

盆骨肿瘤的病灶外切除术

Makhson, A